Diener A M, Beatty P G, Ochs H D, Harlan J M
J Immunol. 1985 Jul;135(1):537-43.
In this study we examined the importance of neutrophil adherence in neutrophil-mediated endothelial cell injury. Phorbol myristate acetate (PMA)-activated neutrophils from a patient with a congenital defect in neutrophil adherence (Gp-150 deficiency) and PMA-activated normal neutrophils pretreated with monoclonal antibody (MoAb) 60.3 were used. Both Gp-150-deficient and MoAb 60.3-treated normal neutrophils failed to adhere to cultured human umbilical vein endothelial cell (HEC) monolayers when activated by PMA (adherence less than 10% with patient and MoAb 60.3-treated cells compared with 53 +/- 3% with normal cells). The addition of PMA-activated normal neutrophils to 51Cr-labeled HEC monolayers failed to induce significant 51Cr release but did produce marked HEC detachment (percentage of detachment 50 +/- 3 at 6 hr). In marked contrast, PMA-activated Gp-150-deficient neutrophils failed to induce significant HEC detachment (percentage of detachment zero (0) at 6 hr). Moreover, the addition of MoAb 60.3 to normal neutrophils inhibited neutrophil-mediated HEC detachment in a time- and dose-dependent fashion. Non-lytic HEC detachment was determined to be largely oxygen radical independent, because PMA-activated chronic granulomatous disease neutrophils and PMA-activated normal neutrophils produced similar disruption of HEC monolayers. Soybean trypsin inhibitor, a chloromethylketone elastase inhibitor, and autologous serum all failed to inhibit neutrophil-mediated HEC detachment. From these studies there is no evidence that nonlytic HEC detachment by PMA-activated neutrophils is mediated by the neutrophil-derived proteases, elastase and cathepsin G. Neutrophil-mediated HEC detachment also required intact neutrophils, because postsecretory medium from PMA-activated normal neutrophils and a suspension of frozen-thawed PMA-activated normal neutrophils were without effect. These in vitro studies indicate that the neutrophil cell surface glycoprotein Gp-150 is required for nonlytic HEC detachment by intact PMA-activated neutrophils.
在本研究中,我们检测了中性粒细胞黏附在中性粒细胞介导的内皮细胞损伤中的重要性。使用了来自一名患有中性粒细胞黏附先天性缺陷(糖蛋白-150缺乏症)患者的佛波酯肉豆蔻酸酯乙酸盐(PMA)激活的中性粒细胞,以及用单克隆抗体(MoAb)60.3预处理的PMA激活的正常中性粒细胞。当被PMA激活时,糖蛋白-150缺乏的中性粒细胞和经MoAb 60.3处理的正常中性粒细胞均无法黏附于培养的人脐静脉内皮细胞(HEC)单层(患者细胞和经MoAb 60.3处理的细胞黏附率低于10%,而正常细胞为53±3%)。将PMA激活的正常中性粒细胞添加到51Cr标记的HEC单层中,未能诱导显著的51Cr释放,但确实导致了明显的HEC脱离(6小时时脱离百分比为50±3)。与之形成鲜明对比的是,PMA激活的糖蛋白-150缺乏的中性粒细胞未能诱导显著的HEC脱离(6小时时脱离百分比为零(0))。此外,向正常中性粒细胞中添加MoAb 60.3以时间和剂量依赖的方式抑制了中性粒细胞介导的HEC脱离。非溶细胞性HEC脱离在很大程度上被确定为不依赖氧自由基,因为PMA激活的慢性肉芽肿病中性粒细胞和PMA激活的正常中性粒细胞对HEC单层产生了类似的破坏。大豆胰蛋白酶抑制剂、一种氯甲基酮弹性蛋白酶抑制剂和自体血清均未能抑制中性粒细胞介导的HEC脱离。从这些研究中,没有证据表明PMA激活的中性粒细胞引起的非溶细胞性HEC脱离是由中性粒细胞衍生的蛋白酶、弹性蛋白酶和组织蛋白酶G介导的。中性粒细胞介导的HEC脱离也需要完整的中性粒细胞,因为PMA激活的正常中性粒细胞的分泌后培养基和冻融的PMA激活的正常中性粒细胞悬液均无作用。这些体外研究表明,完整的PMA激活的中性粒细胞引起的非溶细胞性HEC脱离需要中性粒细胞细胞表面糖蛋白Gp-150。